597 related articles for article (PubMed ID: 10924137)
21. Control of electron transfer in neuronal NO synthase.
Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
[TBL] [Abstract][Full Text] [Related]
22. Characterization of recombinant Bacillus megaterium cytochrome P-450 BM-3 and its two functional domains.
Li HY; Darwish K; Poulos TL
J Biol Chem; 1991 Jun; 266(18):11909-14. PubMed ID: 1904873
[TBL] [Abstract][Full Text] [Related]
23. Electron transfer between the FMN and heme domains of cytochrome P450BM-3. Effects of substrate and CO.
Hazzard JT; Govindaraj S; Poulos TL; Tollin G
J Biol Chem; 1997 Mar; 272(12):7922-6. PubMed ID: 9065460
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the structural stability of the multidomain enzyme flavocytochrome P-450 BM3.
Munro AW; Lindsay JG; Coggins JR; Kelly SM; Price NC
Biochim Biophys Acta; 1996 Sep; 1296(2):127-37. PubMed ID: 8814218
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of the re-face loop spanning residues 536-541 and its interactions with the cofactor in the flavin mononucleotide-binding domain of flavocytochrome P450 from Bacillus megaterium.
Kasim M; Chen HC; Swenson RP
Biochemistry; 2009 Jun; 48(23):5131-41. PubMed ID: 19432415
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
27. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
28. The flavoprotein component of the Escherichia coli sulfite reductase: expression, purification, and spectral and catalytic properties of a monomeric form containing both the flavin adenine dinucleotide and the flavin mononucleotide cofactors.
Zeghouf M; Fontecave M; Macherel D; Covès J
Biochemistry; 1998 Apr; 37(17):6114-23. PubMed ID: 9558350
[TBL] [Abstract][Full Text] [Related]
29. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
30. The domain architecture of cytochrome P450BM-3.
Govindaraj S; Poulos TL
J Biol Chem; 1997 Mar; 272(12):7915-21. PubMed ID: 9065459
[TBL] [Abstract][Full Text] [Related]
31. Structure of a cytochrome P450-redox partner electron-transfer complex.
Sevrioukova IF; Li H; Zhang H; Peterson JA; Poulos TL
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1863-8. PubMed ID: 10051560
[TBL] [Abstract][Full Text] [Related]
32. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase.
Vermilion JL; Ballou DP; Massey V; Coon MJ
J Biol Chem; 1981 Jan; 256(1):266-77. PubMed ID: 6778861
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
Hodgson AV; Strobel HW
Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
[TBL] [Abstract][Full Text] [Related]
34. Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450(BM-3).
Li H; Poulos TL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):141-9. PubMed ID: 10570242
[TBL] [Abstract][Full Text] [Related]
35. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
36. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
[TBL] [Abstract][Full Text] [Related]
37. The FMN to heme electron transfer in cytochrome P450BM-3. Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site.
Sevrioukova IF; Hazzard JT; Tollin G; Poulos TL
J Biol Chem; 1999 Dec; 274(51):36097-106. PubMed ID: 10593892
[TBL] [Abstract][Full Text] [Related]
38. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains.
Narayanasami R; Horowitz PM; Masters BS
Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627
[TBL] [Abstract][Full Text] [Related]
39. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
[TBL] [Abstract][Full Text] [Related]
40. Expression and characterization of the two flavodoxin proteins of Bacillus subtilis, YkuN and YkuP: biophysical properties and interactions with cytochrome P450 BioI.
Lawson RJ; von Wachenfeldt C; Haq I; Perkins J; Munro AW
Biochemistry; 2004 Oct; 43(39):12390-409. PubMed ID: 15449930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
